{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:15:30Z","timestamp":1754162130718,"version":"3.41.2"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2003,8,1]],"date-time":"2003-08-01T00:00:00Z","timestamp":1059696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2003,8,1]],"date-time":"2003-08-01T00:00:00Z","timestamp":1059696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2003,8]]},"DOI":"10.1023\/a:1025456224751","type":"journal-article","created":{"date-parts":[[2003,9,19]],"date-time":"2003-09-19T17:36:12Z","timestamp":1063992972000},"page":"269-279","source":"Crossref","is-referenced-by-count":6,"title":["The alkylating agent penclomedine induces degeneration of purkinje cells in the rat cerebellum"],"prefix":"10.1007","volume":"21","author":[{"given":"Seamus","family":"O'Reilly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"O'Hearn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert F.","family":"Struck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric K.","family":"Rowinsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark E.","family":"Molliver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"5139827_CR1","first-page":"1909","volume":"49","author":"J Plowman","year":"1989","unstructured":"Plowman J, Harrison SD, Jr, Dykes DJ, Paull KD, Narayanan V, Tobol HK, Griswold DP, Jr: Preclinical antitumor activity of an alpha picoline derivative, penclomedine (NSC 338720), on human and murine tumors. Cancer Res 49: 1909\u20131915, 1989","journal-title":"Cancer Res"},{"key":"5139827_CR2","first-page":"1979","volume":"51","author":"SD Harrison Jr","year":"1991","unstructured":"Harrison SD, Jr, Plowman J, Dykes DJ, Waud WR and Griswold DP, Jr: Preclinical antitumor activity of penclomedine in mice: cross resistance, schedule dependence, and oral activity against tumor xenografts in brain. Cancer Res 51: 1979\u20131983, 1991","journal-title":"Cancer Res"},{"key":"5139827_CR3","first-page":"2830","volume":"52","author":"JM Reid","year":"1992","unstructured":"Reid JM, Mathieson DA, Benson LM, Kuffel MJ, Ames MM: Murine pharmacokinetics and metabolism of penclomedine [3,5\u2013dichloro-2,4\u2013dimethoxy-6\u2013(trichloromethyl)pyridine, NSC 338720]. Cancer Res 52: 2830\u20132834, 1992","journal-title":"Cancer Res"},{"key":"5139827_CR4","first-page":"953","volume":"2","author":"NR Hartman","year":"1996","unstructured":"Hartman NR, O'Reilly S, Rowinsky EK, Collins J, Strong JM: Murine and human in vivo penclomedine metabolism. Clin Cancer Res 2: 953\u2013962, 1996","journal-title":"Clin Cancer Res"},{"key":"5139827_CR5","first-page":"541","volume":"2","author":"S O'Reilly","year":"1996","unstructured":"O'Reilly S, Hartman NR, Grossman SA, Strong JM, Struck RF, Eller S, Lesser GJ, Donehower RC, Rowinsky EK: Tissue and tumor distribution of 14C-penclomedine in rats. Clin Cancer Res 2: 541\u2013548, 1996","journal-title":"Clin Cancer Res"},{"key":"5139827_CR6","volume-title":"Pharmacologic Studies of Penclomedine","author":"S O'Reilly","year":"1996","unstructured":"O'Reilly, S: Pharmacologic Studies of Penclomedine. Doctoral dissertation. Johns Hopkins University\/Johns Hopkins University Press, Baltimore, MD, 1996"},{"key":"5139827_CR7","first-page":"815","volume":"57","author":"WR Waud","year":"1997","unstructured":"Waud WR, Tiwari A, Schmid SM, Shih TW, Strong JM, Hartman NR, O'Reilly S, Struck RF: 4\u2013Demethylpenclomedine, an antitumor active, non-neurotoxic metabolite of penclomedine. Cancer Res 57: 815\u2013817, 1997","journal-title":"Cancer Res"},{"key":"5139827_CR8","first-page":"218","volume":"39","author":"H Freidman","year":"1998","unstructured":"Freidman H, Keir S, Bigner D, Struck, R: Treatment of CNS tumor xenografts with penclomedine and 4\u2013demethylpenclomedine. Proc Amer Assoc Cancer Res 39: 218, 1998 (Abstract)","journal-title":"Proc Amer Assoc Cancer Res"},{"key":"5139827_CR9","volume-title":"Penclomedine Investigators Brochure","author":"Division of Cancer Treatment, DiagnosisCenters, National Cancer Institute","year":"1992","unstructured":"Division of Cancer Treatment, Diagnosis and Centers, National Cancer Institute: Penclomedine Investigators Brochure. National Cancer Institute, Bethesda, MD, 1992"},{"key":"5139827_CR10","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1200\/JCO.1997.15.5.1974","volume":"15","author":"S O'Reilly","year":"1997","unstructured":"O'Reilly S, Grochow LB, Donehower RC, Bowling K, Chen TL, Hartman N, Struck RF, Rowinsky EK: Phase I and pharmacologic study of penclomedine, a novel alkylating agent, in patients with solid tumors. J Clin Oncol 15: 1974\u20131984, 1997","journal-title":"J Clin Oncol"},{"key":"5139827_CR11","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1200\/JCO.1998.16.3.1142","volume":"16","author":"J Berlin","year":"1998","unstructured":"Berlin J, Stewart JA, Storer B, Tutsch KD, Arzoomanian RZ, Alberti D, Feierabend C, Simon K, Wilding, G: Phase I clinical and pharmacokinetic trial of penclomedine using a novel, two-stage trial design for patients with advanced malignancy. J Clin Oncol 16: 1142\u20131149, 1998","journal-title":"J Clin Oncol"},{"key":"5139827_CR12","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/bjc.1998.131","volume":"77","author":"DI Jodrell","year":"1998","unstructured":"Jodrell DI, Bowman A, Stewart M, Dunlop N, French R, MacLellan A, Cummings J, Smyth JF: Dose-limiting neurotoxicity in a phase I study of penclomedine (NSC 388720, CRC 88\u201304), a synthetic alpha-picoline derivative, administered intravenously. Br J Cancer 77: 808\u2013811, 1998","journal-title":"Br J Cancer"},{"key":"5139827_CR13","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/0166-2236(96)10049-7","volume":"19","author":"GW Kreutzberg","year":"1996","unstructured":"Kreutzberg GW: Microglia: a sensor for pathological events in the CNS. Trends Neurosci 19: 312\u2013318, 1996","journal-title":"Trends Neurosci"},{"key":"5139827_CR14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0165-0173(92)90007-9","volume":"17","author":"WE Thomas","year":"1992","unstructured":"Thomas WE: Brain macrophages: evaluation of microglia and their functions. Brain Res Rev 17: 61\u201374, 1992","journal-title":"Brain Res Rev"},{"key":"5139827_CR15","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/j.1460-9568.1990.tb00023.x","volume":"2","author":"JM Sequier","year":"1990","unstructured":"Sequier JM, Hunziker W, Andressen C, Celio MR: Calbindin D28K protein and mRNA localization in the rat brain. Eur J Neurosci 2: 1118\u20131126, 1990","journal-title":"Eur J Neurosci"},{"key":"5139827_CR16","first-page":"219","volume":"50","author":"EJ Freireich","year":"1966","unstructured":"Freireich EJ, Gehan EA, Rall DP, Schmidt LH, Skipper HE: Quantitative comparison of toxicity of anti-cancer agents in mouse, rat, dog, monkey and man. Cancer Chemother Rep 50: 219\u2013244, 1966","journal-title":"Cancer Chemother Rep"},{"key":"5139827_CR17","first-page":"299","volume":"4","author":"E O'Hearn","year":"1993","unstructured":"O'Hearn E, Long DB, Molliver ME: Ibogaine induces glial activation in parasagittal zones in the cerebellum. Neuro-Report 4: 299\u2013302, 1993","journal-title":"Neuro-Report"},{"key":"5139827_CR18","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/cne.903140312","volume":"314","author":"LA Mamounas","year":"1991","unstructured":"Mamounas LA, Mullen CA, O'Hearn E, Molliver ME: Dual serotonergic projections to forebrain in the rat: morphologically distinct 5\u2013HT axon terminals exhibit differential vulnerability to neurotoxic amphetamine derivatives. J Comp Neurol 314: 435\u2013440, 1991","journal-title":"J Comp Neurol"},{"key":"5139827_CR19","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0306-4522(93)90500-F","volume":"55","author":"E O'Hearn","year":"1993","unstructured":"O'Hearn E, Molliver ME: Degeneration of Purkinje cells in parasagittal zones in the cerebellar vermis after treatment with ibogaine or harmaline. Neuroscience 55: 303\u2013310, 1993","journal-title":"Neuroscience"},{"key":"5139827_CR20","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1523\/JNEUROSCI.15-03-02097.1995","volume":"15","author":"R N\u00e4kki","year":"1995","unstructured":"N\u00e4kki R, Koistinaho J, Sharp FR, Sagar SM: Cerebellar toxicity of phencyclidine. J Neurosci 15: 2097\u20132108, 1995","journal-title":"J Neurosci"},{"key":"5139827_CR21","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1113\/jphysiol.1986.sp016147","volume":"376","author":"R Llin\u00e1s","year":"1986","unstructured":"Llin\u00e1s R, Yarom Y: Oscillatory properties of guinea-pig inferior olivary neurons and their pharmacological modulation: an in vitro study. J Physiol 376: 163\u2013182, 1986","journal-title":"J Physiol"},{"key":"5139827_CR22","doi-asserted-by":"crossref","first-page":"8828","DOI":"10.1523\/JNEUROSCI.17-22-08828.1997","volume":"17","author":"E O'Hearn","year":"1997","unstructured":"O'Hearn E, Molliver ME: The olivocerebellar projection mediates ibogaine-induced degeneration of Purkinje cells: a model of indirect, trans-synaptic excitotoxicity. J Neurosci 17: 8828\u20138841, 1997","journal-title":"J Neurosci"},{"key":"5139827_CR23","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/978-1-4612-1602-5_11","volume-title":"Cell Death and Diseases of the Nervous System","author":"E O'Hearn","year":"1999","unstructured":"O'Hearn E, Molliver ME: Neurotoxins and neuronal death: an animal model of excitotoxicity. In: Koliatsos VE, Ratan RR (eds) Cell Death and Diseases of the Nervous System. Human Press Inc., Totowa, NJ, 1999, pp 221\u2013245"},{"key":"5139827_CR24","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1146\/annurev.pa.32.040192.002313","volume":"32","author":"P Nicotera","year":"1992","unstructured":"Nicotera P, Bellomo G, Orrenius S: Calcium-mediated mechanisms in chemically induced cell death. Annu Rev Pharmacol Toxicol 32: 449\u2013470, 1992","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"5139827_CR25","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0896-6273(88)90076-1","volume":"1","author":"R Siman","year":"1988","unstructured":"Siman R, Noszek JC: Excitatory amino acids activate calpain I and induce structural protein breakdown in vivo. Neuron 1: 279\u2013287, 1988","journal-title":"Neuron"},{"key":"5139827_CR26","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1460-9568.1989.tb00365.x","volume":"1","author":"R Llin\u00e1s","year":"1989","unstructured":"Llin\u00e1s R, Sasaki K: The functional organization of the olivocerebellar system as examined by multiple Purkinje cell recordings. Eur J Neurosci 1: 587\u2013602, 1989","journal-title":"Eur J Neurosci"},{"key":"5139827_CR27","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1152\/jn.1976.39.2.311","volume":"39","author":"R Llin\u00e1s","year":"1976","unstructured":"Llin\u00e1s R, Nicholson C: Reversal properties of climbing fiber potential in cat Purkinje cells: an example of a distributed synapse. J Neurophysiol 39: 311\u2013323, 1976","journal-title":"J Neurophysiol"},{"key":"5139827_CR28","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/ana.410140505","volume":"14","author":"MD Winkelman","year":"1983","unstructured":"Winkelman MD, Hines JD: Cerebellar degeneration caused by high dose cytosine arabinoside: a clinicopathologic study. Ann Neurol 14: 520\u2013527, 1983","journal-title":"Ann Neurol"},{"key":"5139827_CR29","first-page":"1037","volume":"11","author":"R Wetts","year":"1985","unstructured":"Wetts R, Moran T, Oster-Granite M, Gearhart J: Effect of Purkinje cell loss on complex motor behavior. Soc Neurosci 11: 1037, 1985 (Abstract)","journal-title":"Soc Neurosci"},{"key":"5139827_CR30","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s002800100346","volume":"48","author":"S O'Reilly","year":"2001","unstructured":"O'Reilly S, Strong J, Bowling K, Rowinsky EK, Donehower RC, Collins J, Hartman NR: A pharmacologic study of the oral bioavailability study of oral penclomedine. Cancer Chemother Pharmacol 48: 223\u2013228, 2001","journal-title":"Cancer Chemother Pharmacol"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1025456224751.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1025456224751\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1025456224751.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T20:02:42Z","timestamp":1753819362000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1025456224751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,8]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,8]]}},"alternative-id":["5139827"],"URL":"https:\/\/doi.org\/10.1023\/a:1025456224751","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"type":"print","value":"0167-6997"},{"type":"electronic","value":"1573-0646"}],"subject":[],"published":{"date-parts":[[2003,8]]}}}